Viewing Study NCT04817618


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-26 @ 3:44 AM
Study NCT ID: NCT04817618
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2021-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module